Global Water Group Fluence will established，China may become key deployment market

Recently, Emefcy and RWL Water proposed a merger bill, and decided to create a new global water group Fluence Corporation. The bill will combine both patent technology and system deployment expertise to create a global growth potential for the business segment. The consolidation will focus on key markets such as municipal, commercial, industrial, mining, oil and gas, electricity and food and beverage sectors, with revenues expected to exceed $90 million in 2017.
"The merger bill is expected to significantly accelerate the deployment of Emefcy in China and other key markets and bring in a large number of sales synergies for Emefcy and RWL Water products and systems," the joint statement said. It is reported that Emefcy shareholders will have a 66% stake in the new company, RWL Water chairman and founder Ronald Lauder will have a 34% stake.
A non binding letter of intent, the two companies will merge with the stock delivery of all the way, and Emefcy to RWL Water's parent company (owned by Lauder) issued 105 million shares of new shares, these shares shall comply with the two RWL Water lock up agreement, can only be sold in limited circumstances. In addition, Lauder or its controlled entity will subscribe for $20 million in Emefcy shares at a projected price of $0.85 ($0.64) for a 20 day weighted average price.
It is reported that the "complementary" to highlight the transaction for each company, including "Water RWL system design, construction and deployment capabilities" and Emefcy's "breakthrough of wastewater treatment technology, the new company will provide comprehensive solutions through professional and technical differentiation, and can accelerate the deployment and commissioning of the new plant it is very important to the China rural wastewater treatment".
The statement said that the new company wastewater treatment solutions to membrane aerated biofilm reactor Emefcy proprietary (MABR) technology and innovation as the focus, as the world's one of the fastest developing water treatment company, RWL Water in more than 70 countries to design and build a more than 7000 device, which will enable the new company. Benefits.
"We expect the merger to create a clear leader in the fastest growing distributed water and wastewater treatment industry in the global water market," said Emefcy chairman Richard Irving. Emefcy has developed a breakthrough technology that substantially reduces the cost of wastewater treatment, but has yet to fully develop its distribution and plant delivery capabilities. And RWL Water has rapidly grown into the world's leading water treatment solutions division and is now pouring new blood into special technology.
The president and CEO of RWL Water, Fluence chief executive Henry Charrab Trust said: "after the merger of the group will cover the full circulation of water treatment capacity -- wastewater desalination wastewater reuse of energy. The new company will build a competitive integrated processing plant in terms of operating costs, rapid deployment capacity and economic operating costs. Distributed processing not only enables remote and developing regions around the world to obtain clean water and sanitation at their affordable prices, but also provides a means of reference to developed countries.
It is reported that RWL Water chief operating officer Philippe Laval will serve as the new company's chief operating officer, Emefcy co-founder and CEO Eytan Levy will serve as president of products and innovation, Emefcy co-founder Ronen Schechter will serve as chief technology officer RWL Water, chief financial officer Bob Wowk will be CFO, Ross Kennedy will continue to serve as secretary of the company.
The Fluence board of directors of the seven strong members will include the board of directors of Emefcy members: Irving, Levy, Ross Haghighat, Peter Marks and Robert Wale; and Charrab and RWL Water the current members of the board of directors, former chief technology officer Rengarajan GE water Ramesh.
It is reported that the new company will be headquartered in New York, the company's operations in Israel will be incorporated into the standard research and production center of Caesarea in israel. Fluence shares will be listed on the Australian Stock Exchange after the completion of the transaction, but the stock transaction must meet the terms of the agreement, the purchase agreement, Emefcy shareholder approval and other customary conditions.